Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Potter

Showing results (651-660 of 778) with videos related to

Pageof 78
Sort By:
Endocrine-Related Cancer|November 8, 2012
STX2171, a 17β-hydroxysteroid dehydrogenase type 3 inhibitor, is efficacious in vivo in a novel hormone-dependent prostate cancer modelJoanna M Day, Paul A Foster, Helena J Tutill, et al.
Biochemistry|May 23, 2002
Novel hydrolysis-resistant analogues of cyclic ADP-ribose: modification of the "northern" ribose and calcium release activityAndreas H Guse, Céline Cakir-Kiefer, Masayoshi Fukuoka, et al.
Cardiovascular Diagnosis and Therapy|February 7, 2017
Stenotic flow reserve derived from quantitative coronary angiography has modest but incremental value in predicting functionally significant coronary stenosis as evaluated by fractional flow reserveElizabeth L Potter, Colin Machado, Yuvaraj Malaiapan, et al.
The Journal of Steroid Biochemistry and Molecular Biology|November 19, 2003
Steroid sulphatase inhibitors for breast cancer therapyA Purohit, L W L Woo, S K Chander, et al.
Journal of Speech, Language, and Hearing Research : JSLHR|May 26, 2023
Virtual Post-Intervention Speech and Language Assessment of Toddler and Preschool Participants in Babble Boot CampNancy L Potter, Mark VanDam, Laurel Bruce, et al.
Journal of Cell Science|April 1, 2004
Amplification and propagation of pacemaker Ca2+ signals by cyclic ADP-ribose and the type 3 ryanodine receptor in T cellsSvenja Kunerth, Matthias F Langhorst, Nadine Schwarzmann, et al.
Bioorganic & Medicinal Chemistry|February 24, 2024
Synthesis, biological evaluation, and stability studies of raloxifene mono- and bis-sulfamates as dual-targeting agentsSeyed-Omar Zaraei, Wolfgang Dohle, Hanan S Anbar, et al.
British Journal of Cancer|February 19, 2004
Pharmacokinetics and efficacy of 2-methoxyoestradiol and 2-methoxyoestradiol-bis-sulphamate in vivo in rodentsC R Ireson, S K Chander, A Purohit, et al.
Journal of Medicinal Chemistry|December 22, 2006
2-substituted estradiol bis-sulfamates, multitargeted antitumor agents: synthesis, in vitro SAR, protein crystallography, and in vivo activityMathew P Leese, Bertrand Leblond, Andrew Smith, et al.
The Biochemical Journal|March 10, 2023
Diversification in the inositol tris/tetrakisphosphate kinase (ITPK) family: crystal structure and enzymology of the outlier AtITPK4Hayley L Whitfield, Sining He, Yinghong Gu, et al.
Pageof 78

Showing results (651-660 of 778) with videos related to

Sort By:
Pageof 78
Endocrine-Related Cancer|November 8, 2012
STX2171, a 17β-hydroxysteroid dehydrogenase type 3 inhibitor, is efficacious in vivo in a novel hormone-dependent prostate cancer modelJoanna M Day, Paul A Foster, Helena J Tutill, et al.
Biochemistry|May 23, 2002
Novel hydrolysis-resistant analogues of cyclic ADP-ribose: modification of the "northern" ribose and calcium release activityAndreas H Guse, Céline Cakir-Kiefer, Masayoshi Fukuoka, et al.
Cardiovascular Diagnosis and Therapy|February 7, 2017
Stenotic flow reserve derived from quantitative coronary angiography has modest but incremental value in predicting functionally significant coronary stenosis as evaluated by fractional flow reserveElizabeth L Potter, Colin Machado, Yuvaraj Malaiapan, et al.
The Journal of Steroid Biochemistry and Molecular Biology|November 19, 2003
Steroid sulphatase inhibitors for breast cancer therapyA Purohit, L W L Woo, S K Chander, et al.
Journal of Speech, Language, and Hearing Research : JSLHR|May 26, 2023
Virtual Post-Intervention Speech and Language Assessment of Toddler and Preschool Participants in Babble Boot CampNancy L Potter, Mark VanDam, Laurel Bruce, et al.
Journal of Cell Science|April 1, 2004
Amplification and propagation of pacemaker Ca2+ signals by cyclic ADP-ribose and the type 3 ryanodine receptor in T cellsSvenja Kunerth, Matthias F Langhorst, Nadine Schwarzmann, et al.
Bioorganic & Medicinal Chemistry|February 24, 2024
Synthesis, biological evaluation, and stability studies of raloxifene mono- and bis-sulfamates as dual-targeting agentsSeyed-Omar Zaraei, Wolfgang Dohle, Hanan S Anbar, et al.
British Journal of Cancer|February 19, 2004
Pharmacokinetics and efficacy of 2-methoxyoestradiol and 2-methoxyoestradiol-bis-sulphamate in vivo in rodentsC R Ireson, S K Chander, A Purohit, et al.
Journal of Medicinal Chemistry|December 22, 2006
2-substituted estradiol bis-sulfamates, multitargeted antitumor agents: synthesis, in vitro SAR, protein crystallography, and in vivo activityMathew P Leese, Bertrand Leblond, Andrew Smith, et al.
The Biochemical Journal|March 10, 2023
Diversification in the inositol tris/tetrakisphosphate kinase (ITPK) family: crystal structure and enzymology of the outlier AtITPK4Hayley L Whitfield, Sining He, Yinghong Gu, et al.
Pageof 78